EirGen Pharma

EirGen Pharma focuses on the development, registration and commercial manufacture of high potency, high barrier to entry solid dose products for the global pharmaceutical market. EirGen Pharma is fully licensed to manufacture oncology, cytotoxic, steroidal and immunosuppressant molecules in a purpose built high containment facility. The state of the art facilities can also handle the development of moisture sensitive molecules in a low humidity environment. The company has an Investigational Medicinal Products (IMP) licence for the manufacture of clinical trial materials and a Manufacturing Licence for commercial manufacturing and packaging. These licences specifically relate to highly potent products. EirGen is also FDA approved for both the facility and products and the facility is also registered with the Japanese PMDA.

Contact details

Westside Business Pk
Old Kilmeaden Rd